World's 1st intra-nasal vaccine for Covid gets CDSCO nod for emergency use
HY News
02 December, 2022 11:52 am IST
Text Size:
World's first intra-nasal vaccine for COVID developed by India has got approval from the Central Drugs Standard Control Organisation (CDSCO) for restricted use in emergency situations in the age group of 18 and above.
This was stated by Union Minister Dr Jitendra Singh, on Thursday, while he was chairing a meeting of the Societies of Autonomous Institutions of the Department of Biotechnology where he also informed about the historic decision to merge the 14 societies of Biotechnology Institutes into a single society in the interest of convenient functioning, cost-effectiveness and integrated working.
Dr Jitendra Singh informed that the Product development and Clinical trials were funded by the Department of Biotechnology, Government of India and BIRAC under the Mission COVID Suraksha Program. This vaccine received approval under restricted Use in emergency situations for ages 18 and above for primary 2 dose schedule, homologous booster doses.
The Minister said that India’s efforts through Mission COVID Suraksha has not only strengthened Atmanirbhar Bharat but also bolstered India’s status as a worldwide vaccine development and manufacturing center.
Subscribe to our mailing list to get the new updates!
Subscribe our newsletter to stay updated
Leave Comments